Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000628520 | SCV000749422 | likely benign | Gorlin syndrome; Medulloblastoma | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001015930 | SCV001176825 | likely benign | Hereditary cancer-predisposing syndrome | 2017-12-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003424197 | SCV004127282 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | SUFU: BP4, BP7 |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003424197 | SCV004221306 | benign | not provided | 2023-02-13 | criteria provided, single submitter | clinical testing |